期刊： CLINICAL BREAST CANCER, 2021; 21 (4)
Breast cancer remains a health burden and the role of miR-432 in breast cancer remains elusive. The clinical study in 117 breast cancer patients and c......
期刊： CLINICAL BREAST CANCER, 2021; 21 (4)
We conducted a cost-effectiveness analysis incorporating recent phase III clinical trial (MONALEESA-7) data to evaluate the cost-effectiveness of ribo......
期刊： CLINICAL BREAST CANCER, 2021; 21 (4)
Invasive micropapillary carcinoma is a highly aggressive histologic subtype of breast cancer. A total of 388 patients with breast invasive micropapill......
期刊： CLINICAL BREAST CANCER, 2021; 21 (3)
The estrogen receptor-1 (ESR1) gene encodes estrogen receptor-alpha, which is a major biomarker in the development of breast cancer. Through case-cont......
期刊： CLINICAL BREAST CANCER, 2021; 21 (1)
This study examined the relationship between BRCA1/2 genetic testing results and surgical method selection in patients with primary unilateral breast ......
期刊： CLINICAL BREAST CANCER, 2021; 21 (4)
This study retrospectively analyzed 215 patients to develop and validate a radiomic nomogram based on staging contrast-enhanced computed tomography fo......
期刊： CLINICAL BREAST CANCER, 2021; 21 (3)
Primary trastuzumab resistance after (neo)adjuvant trastuzumab is an important but tough issue. We conducted a retrospective analysis including 1096 p......
期刊： CLINICAL BREAST CANCER, 2021; 21 (1)
Recognizing that breast cancers present as firm, stiff lesions, the foundation of breast magnetic resonance elastography (MRE) is to combine tissue st......
期刊： CLINICAL BREAST CANCER, 2021; 21 (4)
Background: Although patients diagnosed with ductal carcinoma in situ (DCIS) harbor excellent overall survival (OS) after breast-conserving therapy, t......
期刊： CLINICAL BREAST CANCER, 2020; 20 (1)
To evaluate the current status of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) detection in China, the data from 12,467 i......
期刊： CLINICAL BREAST CANCER, 2020; 20 (1)
This research analyzed the clinical value of programmed death ligand 1 positivity in predicting the outcome of patients with breast cancer. The databa......
期刊： CLINICAL BREAST CANCER, 2020; 20 (1)
The incidence of breast cancer across the world has been on the rise in recent decades. Because identified risk factors can only explain a relatively ......
期刊： CLINICAL BREAST CANCER, 2020; 20 (2)
Hormone receptors (HRs) are important for the management of breast cancer. We evaluated the clinical characteristics and outcomes of single versus dou......
期刊： CLINICAL BREAST CANCER, 2020; 20 (2)
MicroRNA-4472 (miR-4472) was upregulated in breast cancer tissues and correlated with aggressive clinicopathologic features. miR-4472 promotes migrati......
期刊： CLINICAL BREAST CANCER, 2020; 20 (2)
We aimed to establish a galactogram grading system (GGS) and investigate its role in identifying breast cancer with nipple discharge. A consecutive se......
